Day One Biopharmaceuticals Stock Price on December 6, 2024

DAWN Stock  USD 12.87  0.03  0.23%   
If you're considering investing in Day Stock, it is important to understand the factors that can impact its price. As of today, the current price of Day One stands at 12.87, as last reported on the 29th of December, with the highest price reaching 13.00 and the lowest price hitting 12.47 during the day. Day One Biopharmaceu secures Sharpe Ratio (or Efficiency) of -0.044, which denotes the company had a -0.044% return per unit of risk over the last 3 months. Day One Biopharmaceuticals exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Day One's Mean Deviation of 1.79, standard deviation of 2.23, and Variance of 4.97 to check the risk estimate we provide.
  
At this time, Day One's Total Stockholder Equity is very stable compared to the past year. As of the 29th of December 2024, Liabilities And Stockholders Equity is likely to grow to about 394.9 M, while Common Stock Total Equity is likely to drop 5,985. . At this time, Day One's Price Book Value Ratio is very stable compared to the past year. As of the 29th of December 2024, Price To Book Ratio is likely to grow to 3.53, while Price Earnings Ratio is likely to drop (6.47). Day Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.044

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsDAWN

Estimated Market Risk

 2.24
  actual daily
19
81% of assets are more volatile

Expected Return

 -0.1
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.04
  actual daily
0
Most of other assets perform better
Based on monthly moving average Day One is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Day One by adding Day One to a well-diversified portfolio.
Price Book
2.3366
Enterprise Value Ebitda
(7.18)
Price Sales
12.7303
Shares Float
69.4 M
Wall Street Target Price
36.4444

Day One Main Headline on 6th of December 2024

Beacon Therapeutics Holdings Limited , a leading ophthalmic gene therapy company with a purpose to save and restore the vision of patients with blinding retinal diseases, today announced the presentation of 3-month interim safety and efficacy results of the Phase 2 DAWN trial in patients with XLRP at the FLORetina-ICOOR Meeting 2024 in Florence, Italy.

Day One Valuation on December 6, 2024

It is possible to determine the worth of Day One on a given historical date. On December 6, 2024 Day was worth 13.5 at the beginning of the trading date compared to the closed value of 13.75. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Day One stock. Still, in general, we apply an absolute valuation method to find Day One's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Day One where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Day One's related companies.
 Open High Low Close Volume
  13.67    13.89    13.16    13.46    881,784  
12/06/2024
  13.50    13.84    13.37    13.75    568,099  
  13.70    13.92    13.47    13.47    755,858  
Backtest Day One  |  Day One History  |  Day One Valuation   PreviousNext  
Open Value
13.5
13.75
Closing Value
20.23
Upside

Day One Trading Date Momentum on December 6, 2024

On December 09 2024 Day One Biopharmaceuticals was traded for  13.47  at the closing time. The top price for the day was 13.92  and the lowest listed price was  13.47 . The trading volume for the day was 755.9 K. The trading history from December 9, 2024 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 2.04% . The overall trading delta against the current closing price is 7.42% .

Day One Biopharmaceu Fundamentals Correlations and Trends

By evaluating Day One's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Day One's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Day financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Day One Stock history

Day One investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Day is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Day One Biopharmaceu will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Day One stock prices may prove useful in developing a viable investing in Day One
Last ReportedProjected for Next Year
Common Stock Shares Outstanding79.8 M72.8 M
Net Loss-128 M-134.4 M

Day One Quarterly Net Working Capital

541.25 Million

Day One Stock Technical Analysis

Day One technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Day One technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Day One trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Day One Period Price Range

Low
December 29, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

Day One Biopharmaceuticals cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Day One December 29, 2024 Market Strength

Market strength indicators help investors to evaluate how Day One stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Day One shares will generate the highest return on investment. By undertsting and applying Day One stock market strength indicators, traders can identify Day One Biopharmaceuticals entry and exit signals to maximize returns

Day One Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Day One's price direction in advance. Along with the technical and fundamental analysis of Day Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Day to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
When determining whether Day One Biopharmaceu offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Day One's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Day One Biopharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Day One Biopharmaceuticals Stock:
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Day One Biopharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in housing.
You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Day One. If investors know Day will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Day One listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.97)
Revenue Per Share
1.144
Return On Assets
(0.25)
Return On Equity
(0.18)
The market value of Day One Biopharmaceu is measured differently than its book value, which is the value of Day that is recorded on the company's balance sheet. Investors also form their own opinion of Day One's value that differs from its market value or its book value, called intrinsic value, which is Day One's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Day One's market value can be influenced by many factors that don't directly affect Day One's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Day One's value and its price as these two are different measures arrived at by different means. Investors typically determine if Day One is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Day One's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.